Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$980M |
| 2 |
Newmont
NEM
|
+$415M |
| 3 |
Moody's
MCO
|
+$313M |
| 4 |
Uber
UBER
|
+$263M |
| 5 |
AbbVie
ABBV
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$981M |
| 2 |
Microsoft
MSFT
|
+$876M |
| 3 |
HES
Hess
HES
|
+$530M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$438M |
| 5 |
Merck
MRK
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.3% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
3601
DELISTED
CARGO Therapeutics
CRGX
| $395K | ﹤0.01% |
+17,067
| New | +$289K |
|
3602
BRC Inc
BRCC
$212M
| $395K | ﹤0.01% |
108,707
+825
| +0.8% | +$2.84K |
|
3603
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.5B
| $395K | ﹤0.01% |
+10,002
| New | +$292K |
|
3604
Copa Holdings
CPA
$6.17B
| $394K | ﹤0.01% |
+3,703
| New | +$339K |
|
3605
FlexShares Quality Dividend Defensive Index Fund
QDEF
$564M
| $393K | ﹤0.01% |
6,659
+1
| +0% | +$56 |
|
|
OMGA
3606
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $393K | ﹤0.01% |
130,445
+57,832
| +80% | +$117K |
|
3607
Eos Energy Enterprises
EOSE
$1.51B
| $392K | ﹤0.01% |
359,816
-201,714
| -36% | -$294K |
|
3608
Medallion Financial
MFIN
$262M
| $392K | ﹤0.01% |
39,751
+1
| +0% | +$8 |
|
3609
Blue Owl Capital
OBDC
$5.87B
| $391K | ﹤0.01% |
26,517
+299
| +1% | +$4.25K |
|
3610
John Hancock Multifactor Mid Cap ETF
JHMM
$6.18B
| $390K | ﹤0.01% |
+7,414
| New | +$358K |
|
3611
Lineage Cell Therapeutics
LCTX
$268M
| $390K | ﹤0.01% |
358,136
+1,275
| +0.4% | +$1.4K |
|
3612
Clover Health Investments
CLOV
$2.38B
| $390K | ﹤0.01% |
409,843
-90,940
| -18% | -$89.3K |
|
3613
Kodiak Sciences
KOD
$2.5B
| $390K | ﹤0.01% |
128,313
+9,680
| +8% | +$21.5K |
|
3614
PMV Pharmaceuticals
PMVP
$65.1M
| $389K | ﹤0.01% |
125,487
+997
| +0.8% | +$2.64K |
|
3615
Principal Spectrum Preferred Securities Active ETF
PREF
$1.78B
| $388K | ﹤0.01% |
22,146
-558,815
| -96% | -$9.42M |
|
3616
Annovis Bio
ANVS
$76.1M
| $387K | ﹤0.01% |
20,705
-13,067
| -39% | -$116K |
|
|
VTYX
3617
DELISTED
Ventyx Biosciences
VTYX
| $385K | ﹤0.01% |
155,911
-8,241
| -5% | -$78.3K |
|
3618
Smartbird Inc
BIRD
$31.2M
| $385K | ﹤0.01% |
15,703
-98
| -0.6% | -$1.93K |
|
3619
Vanguard Russell 1000 Value ETF
VONV
$22B
| $384K | ﹤0.01% |
5,292
-4
| -0.1% | -$271 |
|
|
BCOV
3620
DELISTED
Brightcove, Inc.
BCOV
| $383K | ﹤0.01% |
147,981
-19,619
| -12% | -$52.7K |
|
|
CGAU
3621
Centerra Gold
CGAU
$4.15B
| $383K | ﹤0.01% |
64,248
+2,473
| +4% | +$13.6K |
|
3622
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.9B
| $382K | ﹤0.01% |
7,960
-8,423
| -51% | -$362K |
|
3623
Noodles & Co
NDLS
$100M
| $378K | ﹤0.01% |
14,993
-13
| -0.1% | -$284 |
|
3624
INmune Bio
INMB
$57.7M
| $376K | ﹤0.01% |
33,400
+509
| +2% | +$4.27K |
|
3625
Anixa Biosciences
ANIX
$109M
| $375K | ﹤0.01% |
96,654
+57
| +0.1% | +$192 |
|
Similar funds
Bank of New York Mellon's Q4 2023 Portfolio in Review
As of Q4 2023, Bank of New York Mellon held 4,468 positions worth $493B, up 8.4% from $455B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2023 filing shows 126 new, 1,615 increased, 2,238 reduced and 158 closed positions. Its largest new stake was Veralto: 3,360,679 shares worth $276M. The largest sale was Apple, an estimated $981M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2023 buy was Veralto: 3,360,679 shares worth $276M.
- Bank of New York Mellon added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $980M increase.
- Bank of New York Mellon's biggest Q4 2023 reduction was Apple, cutting an estimated $981M.
- Bank of New York Mellon fully exited Activision Blizzard in Q4 2023, selling an estimated $438M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $493B portfolio in Q4 2023.
- Bank of New York Mellon opened 126 new positions and closed 158 in Q4 2023.
- Bank of New York Mellon's portfolio value rose 8.4% quarter-over-quarter to $493B.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.